Target intelligence / Profile preview

Ribosomal protein L36 pseudogene 13 (RPL36P13)

Target
RPL36P13
Molecular classification
Other (pseudogene)
01

Overview

RPL36P13 is a human pseudogene identified as "Ribosomal protein L36 pseudogene 13". Pseudogenes arise from protein-coding genes but have lost their ability to encode functional proteins due to mutations, insertions, deletions, or genomic rearrangements. RPL36P13 is related to (but distinct from) RPL36, which encodes the actual functional ribosomal protein L36—a structural component of the 60S ribosomal subunit involved in cellular protein synthesis. Unlike RPL36, RPL36P13 does not encode any active protein, is not involved in any known biological function or disease process, and is not considered a therapeutic target, receptor, enzyme, or biomarker. Its annotation is strictly as a genomic pseudogene—an inactive remnant of a ribosomal protein gene[6][5]. Key notes: - RPL36P13 should not be regarded as a receptor, enzyme, transporter, or any canonical therapeutic target. - There is no functional protein product, biological activity, disease relevance, or drug interactions described for this pseudogene[6][5]. - There is nothing therapeutically notable about this pseudogene, and its inclusion as a drug target or biomarker would be incorrect. If you require information about the functional ribosomal protein, refer to RPL36 (Ribosomal protein L36) instead[3][4].

Other names
RPL36P13Ribosomal protein L36 pseudogene 13

Beyond the preview

Go deeper on Ribosomal protein L36 pseudogene 13 (RPL36P13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36 pseudogene 13 (RPL36P13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call